Article(id=1322190401197429213, tenantId=1146029695717560320, journalId=1319373162502258839, issueId=1322190316019499694, articleNumber=null, orderNo=null, doi=10.16016/j.2097-0927.202505045, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1747756800000, receivedDateStr=2025-05-21, revisedDate=1750348800000, revisedDateStr=2025-06-20, acceptedDate=null, acceptedDateStr=null, onlineDate=1793164356755, onlineDateStr=2026-10-28, pubDate=1756483200000, pubDateStr=2025-08-30, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793164356755, onlineIssueDateStr=2026-10-28, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793164356755, creator=13701087609, updateTime=1793164356755, updator=13701087609, issue=Issue{id=1322190316019499694, tenantId=1146029695717560320, journalId=1319373162502258839, year='2025', volume='47', issue='16', pageStart='1825', pageEnd='1980', issueExtLink='null', onlineDate='null', pubDate='1756483200000', pubDateStr='2025-08-30', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=0, createTime=1793164336447, creator='13701087609', updateTime=1793164553187, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1322191225206198613, tenantId=1146029695717560320, journalId=1319373162502258839, issueId=1322190316019499694, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1322191225206198614, tenantId=1146029695717560320, journalId=1319373162502258839, issueId=1322190316019499694, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1825, endPage=1837, ext={EN=ArticleExt(id=1322190401428115934, articleId=1322190401197429213, tenantId=1146029695717560320, journalId=1319373162502258839, language=EN, title=Translational opportunities and barriers for blood-based biomarkers in Alzheimer’s disease: from discovery to implementation, columnId=1320434417353470541, journalTitle=Journal of Army Medical University, columnName=Expert Review, runingTitle=null, highlight=null, articleAbstract=
Alzheimer's disease (AD) is the most common type of dementia in the elderly population, imposed a substantial burden on families and society in China. Recent breakthroughs in anti-amyloid beta (Aβ) monoclonal antibody therapies have highlighted the urgent need for early and accurate diagnosis of AD. The advancement of highly sensitive and automated detection platforms for fluid biomarkers has positioned blood biomarkers (BBs) testing as promising tools for early detection, accurate diagnosis, progression monitoring, and therapeutic evaluation in AD. However, their clinical application still faces challenges, including standardization of detection and sample preprocessing, quality control, and confounding factors. Ongoing development of detection technologies and integration of artificial intelligence-driven analytical tools offer promising solutions to these challenges. In the future, efforts should focus on clinical translation pathways, multimodal integration, personalized medicine, and fostering global and national collaborations to accelerate the clinical application of BBs for AD.
, authors=Yanjiang WANG, Shan HUANG, authorsList=Yanjiang WANG, Shan HUANG, authorCompany=null, correspAuthors=Yanjiang WANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=© 2025 Journal of Army Medical University, copyrightOwner=Editorial Office of Journal of Army Medical University, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1322190402023707103, articleId=1322190401197429213, tenantId=1146029695717560320, journalId=1319373162502258839, language=CN, title=阿尔茨海默病血液标志物的突破与挑战:从实验室到临床的转化之路, columnId=1320434417496076879, journalTitle=陆军军医大学学报, columnName=专家述评, runingTitle=null, highlight=null, articleAbstract=
阿尔茨海默病(Alzheimer’s disease,AD)作为老年人群中最常见的神经退行性疾病,其防治已成为全球公共卫生的重要议题。我国AD患病率持续攀升,构成了严峻的社会医疗挑战。随着靶向β淀粉样蛋白(Amyloid-β,Aβ)的单克隆抗体类药物在临床治疗中取得突破性进展,建立早期精准诊断体系的需求日益凸显。在此背景下,基于高灵敏度自动化检测平台的血液生物标志物技术展现出独特优势,为AD的早期筛查、精准分型、病程动态监测及治疗响应评估提供了全新解决方案。然而,该技术的临床转化仍面临诸多挑战,包括检测标准化、样本前处理规范、质量控制体系建立以及复杂系统因素的干扰等。当前,通过持续优化检测技术并结合人工智能辅助分析,有望突破这些技术瓶颈。展望未来,AD血液标志物研究应重点关注以下方向:建立规范的临床转化路径、开发多模态整合诊断模型、挖掘个性化医疗潜力,以及加强全球多中心协作网络建设,从而加速其从实验室到临床的转化进程。
, authors=王延江, 黄珊, authorsList=王延江, 黄珊, authorCompany=null, correspAuthors=王延江, authorNote=null, correspAuthorsNote=
王延江,医学博士,主任医师、教授、博士生导师,陆军军医大学大坪医院神经内科主任。获得国家杰出青年科学基金资助,入选教育部“长江学者”特聘教授、国家“万人计划”领军人才。担任中华医学会神经病学分会常委、中国神经科学学会理事、Vas-Cog Asia(亚洲血管性认知障碍学会)理事。承担国家重点研发计划、国家自然科学基金重点项目等课题,从系统角度探索阿尔茨海默病,提出新理论,发现新药物,建立新技术,开展全国和国际多中心临床试验进行转化研究。以通讯作者在PNAS、Nat Aging、Nat Rev Neurol、Lancet Infect Dis、JAMA Neurol、Sci Adv等杂志发表论文100余篇,获得国家科技进步二等奖、省部级一等奖、第20届Alzheimer Award 。E-mail:
yanjiang_wang@tmmu.edu.cn, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=CEQtONk0MqfIqCgI+ceSvw==, magXml=QM57LNArXf15jUrhIxmwHQ==, pdfUrl=null, pdf=nsgvvOesfbmjdv9QPcTT0g==, pdfFileSize=650796, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=BFcNEZPPMH+B4n3lupmVQw==, mapNumber=null, fund=null)}, authors=[Author(id=1322190404263465444, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=yanjiang_wang@tmmu.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1322190404355740134, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, authorId=1322190404263465444, language=EN, stringName=Yanjiang WANG, firstName=Yanjiang, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=
1Department of Neurology,Chongqing Key Laboratory of Aging and Brain Diseases,Army Medical Center of PLA/Daping Hospital of Third Military Medical University,Chongqing,China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322190404443820519, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, authorId=1322190404263465444, language=CN, stringName=王延江, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=
1陆军特色医学中心(第三军医大学大坪医院)神经内科,衰老与脑疾病重庆市重点实验室,重庆, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322190404154413536, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, xref=1, ext=[AuthorCompanyExt(id=1322190404162802145, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, companyId=1322190404154413536, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1Department of Neurology,Chongqing Key Laboratory of Aging and Brain Diseases,Army Medical Center of PLA/Daping Hospital of Third Military Medical University,Chongqing,China), AuthorCompanyExt(id=1322190404175385058, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, companyId=1322190404154413536, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1陆军特色医学中心(第三军医大学大坪医院)神经内科,衰老与脑疾病重庆市重点实验室,重庆)])]), Author(id=1322190404531900905, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322190404632564204, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, authorId=1322190404531900905, language=EN, stringName=Shan HUANG, firstName=Shan, middleName=null, lastName=HUANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=
1Department of Neurology,Chongqing Key Laboratory of Aging and Brain Diseases,Army Medical Center of PLA/Daping Hospital of Third Military Medical University,Chongqing,China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322190404729033197, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, authorId=1322190404531900905, language=CN, stringName=黄珊, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=
1陆军特色医学中心(第三军医大学大坪医院)神经内科,衰老与脑疾病重庆市重点实验室,重庆, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322190404154413536, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, xref=1, ext=[AuthorCompanyExt(id=1322190404162802145, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, companyId=1322190404154413536, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1Department of Neurology,Chongqing Key Laboratory of Aging and Brain Diseases,Army Medical Center of PLA/Daping Hospital of Third Military Medical University,Chongqing,China), AuthorCompanyExt(id=1322190404175385058, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, companyId=1322190404154413536, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1陆军特色医学中心(第三军医大学大坪医院)神经内科,衰老与脑疾病重庆市重点实验室,重庆)])])], keywords=[Keyword(id=1322190404833890798, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, language=EN, orderNo=1, keyword=Alzheimer’s disease), Keyword(id=1322190404913582575, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, language=EN, orderNo=2, keyword=blood biomarkers), Keyword(id=1322190404989080048, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, language=EN, orderNo=3, keyword=early diagnosis), Keyword(id=1322190405068771825, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, language=EN, orderNo=4, keyword=precision medicine), Keyword(id=1322190405173629426, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, language=EN, orderNo=5, keyword=translational medical research), Keyword(id=1322190405249126899, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, language=CN, orderNo=1, keyword=阿尔茨海默病), Keyword(id=1322190405333012980, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, language=CN, orderNo=2, keyword=血液标志物), Keyword(id=1322190405395927541, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, language=CN, orderNo=3, keyword=早期诊断), Keyword(id=1322190405458842102, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, language=CN, orderNo=4, keyword=精准医学), Keyword(id=1322190405525950967, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, language=CN, orderNo=5, keyword=转化医学研究)], refs=[Reference(id=1322190406234788348, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1002/alz.13809, pmid=null, pmcid=null, year=2024, volume=null, issue=20, pageStart=3708, pageEnd=3821, url=null, language=null, rfNumber=1, rfOrder=0, authorNames=2024 Alzheimer’s disease facts and figures, journalName=Alzheimers Dement, refType=null, unstructuredReference=2024 Alzheimer’s disease facts and figures.
Alzheimers Dement,
2024,20:3708-3821., articleTitle=null, refAbstract=null), Reference(id=1322190406306091517, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1016/S1474-4422(19)30290-X, pmid=null, pmcid=null, year=2020, volume=19, issue=null, pageStart=81, pageEnd=92, url=null, language=null, rfNumber=2, rfOrder=1, authorNames=JIA L, QUAN M, FU Y, journalName=Lancet Neurol, refType=null, unstructuredReference=
JIA L,
QUAN M,
FU Y,
et al. Dementia in China:epidemiology,clinical management,and research advances[J].
Lancet Neurol,
2020,
19:81-92., articleTitle=Dementia in China:epidemiology,clinical management,and research advances, refAbstract=null), Reference(id=1322190406364811774, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1056/NEJMoa2212948, pmid=null, pmcid=null, year=2023, volume=388, issue=null, pageStart=9, pageEnd=21, url=null, language=null, rfNumber=3, rfOrder=2, authorNames=VAN DYCK CH, SWANSON CJ, AISEN P, journalName=N Engl J Med, refType=null, unstructuredReference=
VAN DYCK CH,
SWANSON CJ,
AISEN P,
et al. Lecanemab in Early Alzheimer’s Disease[J].
N Engl J Med,
2023,
388:9-21., articleTitle=Lecanemab in Early Alzheimer’s Disease, refAbstract=null), Reference(id=1322190406654218751, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1001/jama.2023.13239, pmid=null, pmcid=null, year=2023, volume=330, issue=null, pageStart=512, pageEnd=527, url=null, language=null, rfNumber=4, rfOrder=3, authorNames=SIMS JR, ZIMMER JA, EVANS CD, journalName=JAMA, refType=null, unstructuredReference=
SIMS JR,
ZIMMER JA,
EVANS CD,
et al. Donanemab in Early Symptomatic Alzheimer Disease:The TRAILBLAZER-ALZ 2 Randomized Clinical Trial[J].
JAMA,
2023,
330:512-527., articleTitle=Donanemab in Early Symptomatic Alzheimer Disease:The TRAILBLAZER-ALZ 2 Randomized Clinical Trial, refAbstract=null), Reference(id=1322190406729716224, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1002/alz.13859, pmid=null, pmcid=null, year=2024, volume=20, issue=null, pageStart=5143, pageEnd=5169, url=null, language=null, rfNumber=5, rfOrder=4, authorNames=JACK CRJ, ANDREWS JS, BEACH TG, journalName=Alzheimers Dement, refType=null, unstructuredReference=
JACK CRJ,
ANDREWS JS,
BEACH TG,
et al. Revised criteria for diagnosis and staging of Alzheimer’s disease:Alzheimer’s Association Workgroup[J].
Alzheimers Dement,
2024,
20:5143-5169., articleTitle=Revised criteria for diagnosis and staging of Alzheimer’s disease:Alzheimer’s Association Workgroup, refAbstract=null), Reference(id=1322190406796825089, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1016/S0140-6736(20)32205-4, pmid=null, pmcid=null, year=2021, volume=397, issue=null, pageStart=1577, pageEnd=1590, url=null, language=null, rfNumber=6, rfOrder=5, authorNames=SCHELTENS P, DE STROOPER B, KIVIPELTO M, journalName=Lancet, refType=null, unstructuredReference=
SCHELTENS P,
DE STROOPER B,
KIVIPELTO M,
et al. Alzheimer’s disease[J].
Lancet,
2021,
397:1577-1590., articleTitle=Alzheimer’s disease, refAbstract=null), Reference(id=1322190406876516867, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1515/cclm-2023-1434, pmid=null, pmcid=null, year=2024, volume=62, issue=null, pageStart=1063, pageEnd=1069, url=null, language=null, rfNumber=7, rfOrder=6, authorNames=ARSLAN B, ZETTERBERG H, ASHTON NJ, journalName=Clin Chem Lab Med, refType=null, unstructuredReference=
ARSLAN B,
ZETTERBERG H,
ASHTON NJ,
et al. Blood-based biomarkers in Alzheimer’s disease - moving towards a new era of diagnostics[J].
Clin Chem Lab Med,
2024,
62:1063-1069., articleTitle=Blood-based biomarkers in Alzheimer’s disease - moving towards a new era of diagnostics, refAbstract=null), Reference(id=1322190407119786500, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1002/alz.13116, pmid=null, pmcid=null, year=2023, volume=19, issue=null, pageStart=4226, pageEnd=4236, url=null, language=null, rfNumber=8, rfOrder=7, authorNames=WANG J, CHEN M, MASTERS CL, journalName=Alzheimers Dement, refType=null, unstructuredReference=
WANG J,
CHEN M,
MASTERS CL,
et al. Translating blood biomarkers into clinical practice for Alzheimer’s disease:Challenges and perspectives[J].
Alzheimers Dement,
2023,
19:4226-4236., articleTitle=Translating blood biomarkers into clinical practice for Alzheimer’s disease:Challenges and perspectives, refAbstract=null), Reference(id=1322190407220449797, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.3969/j.issn.2096-5516.2024.04.009, pmid=null, pmcid=null, year=2024, volume=7, issue=4, pageStart=287, pageEnd=292, url=null, language=null, rfNumber=9, rfOrder=8, authorNames=王俊, 黄珊, 王延江, journalName=阿尔茨海默病及相关病杂志, refType=null, unstructuredReference=王俊,黄珊,王延江. 阿尔茨海默病血液标志物临床转化的挑战和展望[J].
阿尔茨海默病及相关病杂志,
2024,
7(4):287-292., articleTitle=阿尔茨海默病血液标志物临床转化的挑战和展望, refAbstract=null), Reference(id=1322190407451136518, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.3969/j.issn.2096-5516.2024.04.009, pmid=null, pmcid=null, year=2024, volume=7, issue=4, pageStart=287, pageEnd=292, url=null, language=null, rfNumber=9, rfOrder=9, authorNames=WANG J, HUANG S, WANG Y J, journalName=Chin J Alzheimers Dis Relat Disord, refType=null, unstructuredReference=
WANG J,
HUANG S,
WANG Y J. Clinical translation of blood biomarkers for Alzheimer’s disease:Challenges and Perspectives[J].
Chin J Alzheimers Dis Relat Disord,
2024,
7(4):287-292., articleTitle=Clinical translation of blood biomarkers for Alzheimer’s disease:Challenges and Perspectives, refAbstract=null), Reference(id=1322190407535022599, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1001/jamaneurol. 2023.5319, pmid=null, pmcid=null, year=2024, volume=81, issue=null, pageStart=255, pageEnd=263, url=null, language=null, rfNumber=10, rfOrder=10, authorNames=ASHTON NJ, BRUM WS, DI MOLFETTA G, journalName=JAMA Neurol, refType=null, unstructuredReference=
ASHTON NJ,
BRUM WS,
DI MOLFETTA G,
et al. Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology[J].
JAMA Neurol,
2024,
81:255-263., articleTitle=Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology, refAbstract=null), Reference(id=1322190407652463112, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1002/alz. 13026, pmid=null, pmcid=null, year=2023, volume=19, issue=11, pageStart=4967, pageEnd=4977, url=null, language=null, rfNumber=11, rfOrder=11, authorNames=THERRIAULT J, SERVAES S, TISSOT C, journalName=Alzheimers Dement, refType=null, unstructuredReference=
THERRIAULT J,
SERVAES S,
TISSOT C,
et al. Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer’s disease[J].
Alzheimers Dement,
2023,
19(11):4967-4977., articleTitle=Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer’s disease, refAbstract=null), Reference(id=1322190407887344137, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1038/s41591-024-02869-z, pmid=null, pmcid=null, year=2024, volume=30, issue=4, pageStart=1085, pageEnd=1095, url=null, language=null, rfNumber=12, rfOrder=12, authorNames=BARTHÉLEMY NR, SALVADÓ G, SCHINDLER SE, journalName=Nat Med, refType=null, unstructuredReference=
BARTHÉLEMY NR,
SALVADÓ G,
SCHINDLER SE,
et al. Highly accurate blood test for Alzheimer’s disease is similar or superior to clinical cerebrospinal fluid tests[J].
Nat Med,
2024,
30(4):1085-1095., articleTitle=Highly accurate blood test for Alzheimer’s disease is similar or superior to clinical cerebrospinal fluid tests, refAbstract=null), Reference(id=1322190407962841610, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1056/NEJMoa2310168, pmid=null, pmcid=null, year=2024, volume=390, issue=8, pageStart=712, pageEnd=722, url=null, language=null, rfNumber=13, rfOrder=13, authorNames=JIA J, NING Y, CHEN M, journalName=N Engl J Med, refType=null, unstructuredReference=
JIA J,
NING Y,
CHEN M,
et al. Biomarker Changes during 20 Years Preceding Alzheimer’s Disease[J].
N Engl J Med,
2024,
390(8):712-722., articleTitle=Biomarker Changes during 20 Years Preceding Alzheimer’s Disease, refAbstract=null), Reference(id=1322190408055116299, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1038/s41591-022-02074-w, pmid=null, pmcid=null, year=2022, volume=28, issue=12, pageStart=2555, pageEnd=2562, url=null, language=null, rfNumber=14, rfOrder=14, authorNames=ASHTON NJ, JANELIDZE S, MATTSSON-CARLGREN N, journalName=Nat Med, refType=null, unstructuredReference=
ASHTON NJ,
JANELIDZE S,
MATTSSON-CARLGREN N,
et al. Differential roles of Aβ42/40,p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring[J].
Nat Med,
2022,
28(12):2555-2562., articleTitle=Differential roles of Aβ42/40,p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring, refAbstract=null), Reference(id=1322190408130613772, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1016/S1474-4422(22)00168-5, pmid=null, pmcid=null, year=2022, volume=21, issue=8, pageStart=726, pageEnd=734, url=null, language=null, rfNumber=15, rfOrder=15, authorNames=OSSENKOPPELE R, VAN DER KANT R, HANSSON O, journalName=Lancet Neurol, refType=null, unstructuredReference=
OSSENKOPPELE R,
VAN DER KANT R,
HANSSON O,
et al. Tau biomarkers in Alzheimer’s disease:towards implementation in clinical practice and trials[J].
Lancet Neurol,
2022,
21(8):726-734., articleTitle=Tau biomarkers in Alzheimer’s disease:towards implementation in clinical practice and trials, refAbstract=null), Reference(id=1322190408306774541, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1002/trc2.12404, pmid=null, pmcid=null, year=2023, volume=9, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=16, rfOrder=16, authorNames=GUEORGUIEVA I, WILLIS BA, CHUA L, journalName=Alzheimers Dement (N Y), refType=null, unstructuredReference=
GUEORGUIEVA I,
WILLIS BA,
CHUA L,
et al. Donanemab exposure and efficacy relationship using modeling in Alzheimer’s disease[J].
Alzheimers Dement (N Y),
2023,
9:e12404., articleTitle=Donanemab exposure and efficacy relationship using modeling in Alzheimer’s disease, refAbstract=null), Reference(id=1322190408390660622, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1038/s41591-025-03617-7, pmid=null, pmcid=null, year=2025, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=17, rfOrder=17, authorNames=HORIE K, SALVADÓ G, KOPPISETTI RK, journalName=Nat Med, refType=null, unstructuredReference=
HORIE K,
SALVADÓ G,
KOPPISETTI RK,
et al. Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer’s disease[J].
Nat Med,
2025., articleTitle=Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer’s disease, refAbstract=null), Reference(id=1322190408466158095, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1002/alz.70038, pmid=null, pmcid=null, year=2025, volume=21, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=18, rfOrder=18, authorNames=WANG J, HUANG S, LAN G, journalName=Alzheimers Dement, refType=null, unstructuredReference=
WANG J,
HUANG S,
LAN G,
et al. Diagnostic accuracy of plasma p-tau217/Aβ42 for Alzheimer’s disease in clinical and community cohorts[J].
Alzheimers Dement,
2025,
21:e70038., articleTitle=Diagnostic accuracy of plasma p-tau217/Aβ42 for Alzheimer’s disease in clinical and community cohorts, refAbstract=null), Reference(id=1322190408529072656, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1038/s41582-024-00977-5, pmid=null, pmcid=null, year=2024, volume=20, issue=6, pageStart=426, pageEnd=439, url=null, language=null, rfNumber=19, rfOrder=19, authorNames=SCHINDLER SE, GALASKO D, PEREIRA AC, journalName=Nat Rev Neurol, refType=null, unstructuredReference=
SCHINDLER SE,
GALASKO D,
PEREIRA AC,
et al. Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer’s Disease[J].
Nat Rev Neurol,
2024,
20(6):426-439., articleTitle=Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer’s Disease, refAbstract=null), Reference(id=1322190410198405649, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1038/s41582-024-00955-x, pmid=null, pmcid=null, year=2024, volume=20, issue=4, pageStart=269, pageEnd=287, url=null, language=null, rfNumber=20, rfOrder=20, authorNames=KHALIL M, TEUNISSEN CE, LEHMANN S, journalName=Nat Rev Neurol, refType=null, unstructuredReference=
KHALIL M,
TEUNISSEN CE,
LEHMANN S,
et al. Neurofilaments as biomarkers in neurological disorders - towards clinical application[J].
Nat Rev Neurol,
2024,
20(4):269-287., articleTitle=Neurofilaments as biomarkers in neurological disorders - towards clinical application, refAbstract=null), Reference(id=1322190410286486035, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1002/alz.12724, pmid=null, pmcid=null, year=2023, volume=19, issue=5, pageStart=1117, pageEnd=1134, url=null, language=null, rfNumber=21, rfOrder=21, authorNames=CHATTERJEE P, PEDRINI S, DOECKE JD, journalName=Alzheimers Dement, refType=null, unstructuredReference=
CHATTERJEE P,
PEDRINI S,
DOECKE JD,
et al. Plasma Aβ42/40 ratio,p-tau181,GFAP,and NfL across the Alzheimer’s disease continuum:A cross-sectional and longitudinal study in the AIBL cohort[J].
Alzheimers Dement,
2023,
19(5):1117-1134., articleTitle=Plasma Aβ42/40 ratio,p-tau181,GFAP,and NfL across the Alzheimer’s disease continuum:A cross-sectional and longitudinal study in the AIBL cohort, refAbstract=null), Reference(id=1322190410378760724, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1002/alz.12166, pmid=null, pmcid=null, year=2021, volume=17, issue=1, pageStart=49, pageEnd=60, url=null, language=null, rfNumber=22, rfOrder=22, authorNames=JIA L, ZHU M, KONG C, journalName=Alzheimers Dement, refType=null, unstructuredReference=
JIA L,
ZHU M,
KONG C,
et al. Blood neuro-exosomal synaptic proteins predict Alzheimer’s disease at the asymptomatic stage[J].
Alzheimers Dement,
2021,
17(1):49-60., articleTitle=Blood neuro-exosomal synaptic proteins predict Alzheimer’s disease at the asymptomatic stage, refAbstract=null), Reference(id=1322190410483618325, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1186/s13195-022-01014-7, pmid=null, pmcid=null, year=2022, volume=14, issue=null, pageStart=71, pageEnd=null, url=null, language=null, rfNumber=23, rfOrder=23, authorNames=VRILLON A, MOUTON-LIGER F, MARTINET M, journalName=Alzheimers Res Ther, refType=null, unstructuredReference=
VRILLON A,
MOUTON-LIGER F,
MARTINET M,
et al. Plasma neuregulin 1 as a synaptic biomarker in Alzheimer’s disease:a discovery cohort study[J].
Alzheimers Res Ther,
2022,
14:71., articleTitle=Plasma neuregulin 1 as a synaptic biomarker in Alzheimer’s disease:a discovery cohort study, refAbstract=null), Reference(id=1322190410571698710, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.3233/JAD-220515, pmid=null, pmcid=null, year=2022, volume=90, issue=4, pageStart=1381, pageEnd=1393, url=null, language=null, rfNumber=24, rfOrder=24, authorNames=ROVETA F, CERMELLI A, BOSCHI S, journalName=J Alzheimers Dis, refType=null, unstructuredReference=
ROVETA F,
CERMELLI A,
BOSCHI S,
et al. Synaptic Proteins as Fluid Biomarkers in Alzheimer’s Disease:A Systematic Review and Meta-Analysis[J].
J Alzheimers Dis,
2022,
90(4):1381-1393., articleTitle=Synaptic Proteins as Fluid Biomarkers in Alzheimer’s Disease:A Systematic Review and Meta-Analysis, refAbstract=null), Reference(id=1322190410634613271, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.3233/JAD-215217, pmid=null, pmcid=null, year=2022, volume=85, issue=2, pageStart=573, pageEnd=585, url=null, language=null, rfNumber=25, rfOrder=25, authorNames=CHEN L, SHEN Q, XU S, journalName=J Alzheimers Dis, refType=null, unstructuredReference=
CHEN L,
SHEN Q,
XU S,
et al. 5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer’s Disease[J].
J Alzheimers Dis,
2022,
85(2):573-585., articleTitle=5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer’s Disease, refAbstract=null), Reference(id=1322190410814968344, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.3390/ijms24032876, pmid=null, pmcid=null, year=2023, volume=24, issue=3, pageStart=2876, pageEnd=null, url=null, language=null, rfNumber=26, rfOrder=26, authorNames=BAHADO-SINGH RO, VISHWESWARAIAH S, TURKOGLU O, journalName=Int J Mol Sci, refType=null, unstructuredReference=
BAHADO-SINGH RO,
VISHWESWARAIAH S,
TURKOGLU O,
et al. Alzheimer’s Precision Neurology:Epigenetics of Cytochrome P450 Genes in Circulating Cell-Free DNA for Disease Prediction and Mechanism[J].
Int J Mol Sci,
2023,
24(3):2876., articleTitle=Alzheimer’s Precision Neurology:Epigenetics of Cytochrome P450 Genes in Circulating Cell-Free DNA for Disease Prediction and Mechanism, refAbstract=null), Reference(id=1322190410882077209, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.14336/AD.2024.0329, pmid=null, pmcid=null, year=2024, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=27, rfOrder=27, authorNames=KHEMKA S, SEHAR U, MANNA PR, journalName=Aging Dis, refType=null, unstructuredReference=
KHEMKA S,
SEHAR U,
MANNA PR,
et al. Cell-Free DNA As Peripheral Biomarker of Alzheimer’s Disease[J].
Aging Dis,
2024., articleTitle=Cell-Free DNA As Peripheral Biomarker of Alzheimer’s Disease, refAbstract=null), Reference(id=1322190410957574682, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1093/brain/awac438, pmid=null, pmcid=null, year=2023, volume=146, issue=6, pageStart=1758, pageEnd=1774, url=null, language=null, rfNumber=28, rfOrder=28, authorNames=GAITSCH H, FRANKLIN RJM, REICH DS, journalName=Brain, refType=null, unstructuredReference=
GAITSCH H,
FRANKLIN RJM,
REICH DS,
et al. Cell-free DNA-based liquid biopsies in neurology[J].
Brain,
2023,
146(6):1758-1774., articleTitle=Cell-free DNA-based liquid biopsies in neurology, refAbstract=null), Reference(id=1322190411125346843, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1126/sciadv.abb1654, pmid=null, pmcid=null, year=2020, volume=6, issue=37, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=29, rfOrder=29, authorNames=TODEN S, ZHUANG J, ACOSTA AD, journalName=Sci Adv, refType=null, unstructuredReference=
TODEN S,
ZHUANG J,
ACOSTA AD,
et al. Noninvasive characterization of Alzheimer’s disease by circulating,cell-free messenger RNA next-generation sequencing[J].
Sci Adv,
2020,
6(37):eabb1654., articleTitle=Noninvasive characterization of Alzheimer’s disease by circulating,cell-free messenger RNA next-generation sequencing, refAbstract=null), Reference(id=1322190411234398748, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1093/brain/awab223, pmid=null, pmcid=null, year=2021, volume=144, issue=11, pageStart=3505, pageEnd=3516, url=null, language=null, rfNumber=30, rfOrder=30, authorNames=PEREIRA JB, JANELIDZE S, SMITH R, journalName=Brain, refType=null, unstructuredReference=
PEREIRA JB,
JANELIDZE S,
SMITH R,
et al. Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease[J].
Brain,
2021,
144(11):3505-3516., articleTitle=Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease, refAbstract=null), Reference(id=1322190411297313309, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1212/WNL.0000000000208075, pmid=null, pmcid=null, year=2024, volume=102, issue=5, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=31, rfOrder=31, authorNames=PASE MP, HIMALI JJ, PUERTA R, journalName=Neurology, refType=null, unstructuredReference=
PASE MP,
HIMALI JJ,
PUERTA R,
et al. Association of Plasma YKL-40 With MRI,CSF,and Cognitive Markers of Brain Health and Dementia[J].
Neurology,
2024,
102(5):e208075., articleTitle=Association of Plasma YKL-40 With MRI,CSF,and Cognitive Markers of Brain Health and Dementia, refAbstract=null), Reference(id=1322190411356033566, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1212/WNL. 0000000000012109, pmid=null, pmcid=null, year=2021, volume=96, issue=12, pageStart=e2944, pageEnd=e2955, url=null, language=null, rfNumber=32, rfOrder=32, authorNames=BELLAVER B, FERRARI-SOUZA JP, UGLIONE DA ROS L, journalName=Neurology, refType=null, unstructuredReference=
BELLAVER B,
FERRARI-SOUZA JP,
UGLIONE DA ROS L,
et al. Astrocyte Biomarkers in Alzheimer Disease:A Systematic Review and Meta-analysis[J].
Neurology,
2021,
96(12):e2944-e2955., articleTitle=Astrocyte Biomarkers in Alzheimer Disease:A Systematic Review and Meta-analysis, refAbstract=null), Reference(id=1322190411427336735, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1186/s13024-018-0247-7, pmid=null, pmcid=null, year=2018, volume=13, issue=null, pageStart=15, pageEnd=null, url=null, language=null, rfNumber=33, rfOrder=33, authorNames=ZHONG L, WANG Z, WANG D, journalName=Mol Neurodegener, refType=null, unstructuredReference=
ZHONG L,
WANG Z,
WANG D,
et al. Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2)[J].
Mol Neurodegener,
2018,
13:15., articleTitle=Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2), refAbstract=null), Reference(id=1322190411519611424, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1093/brain/awab332, pmid=null, pmcid=null, year=2021, volume=144, issue=12, pageStart=3371, pageEnd=3380, url=null, language=null, rfNumber=34, rfOrder=34, authorNames=H-H TSAI, CHEN Y-F, YEN R-F, journalName=Brain, refType=null, unstructuredReference=
H-H TSAI,
CHEN Y-F,
YEN R-F,
et al. Plasma soluble TREM2 is associated with white matter lesions independent of amyloid and tau[J].
Brain,
2021,
144(12):3371-3380., articleTitle=Plasma soluble TREM2 is associated with white matter lesions independent of amyloid and tau, refAbstract=null), Reference(id=1322190411653829153, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.3233/JAD-210552, pmid=null, pmcid=null, year=2021, volume=84, issue=3, pageStart=835, pageEnd=842, url=null, language=null, rfNumber=35, rfOrder=35, authorNames=HAO J, QIAO Y, LI T, journalName=J Alzheimers Dis, refType=null, unstructuredReference=
HAO J,
QIAO Y,
LI T,
et al. Investigating Changes in the Serum Inflammatory Factors in Alzheimer’s Disease and Their Correlation with Cognitive Function[J].
J Alzheimers Dis,
2021,
84(3):835-842., articleTitle=Investigating Changes in the Serum Inflammatory Factors in Alzheimer’s Disease and Their Correlation with Cognitive Function, refAbstract=null), Reference(id=1322190411758686754, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1186/s13195-023-01254-1, pmid=null, pmcid=null, year=2023, volume=15, issue=null, pageStart=107, pageEnd=null, url=null, language=null, rfNumber=36, rfOrder=36, authorNames=ZHOU F, SUN Y, XIE X, journalName=Alzheimers Res Ther, refType=null, unstructuredReference=
ZHOU F,
SUN Y,
XIE X,
et al. Blood and CSF chemokines in Alzheimer’s disease and mild cognitive impairment:a systematic review and meta-analysis[J].
Alzheimers Res Ther,
2023,
15:107., articleTitle=Blood and CSF chemokines in Alzheimer’s disease and mild cognitive impairment:a systematic review and meta-analysis, refAbstract=null), Reference(id=1322190411867738659, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1136/bmjopen-2021-054347, pmid=null, pmcid=null, year=2022, volume=12, issue=3, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=37, rfOrder=37, authorNames=WANG T, WANG X, YAO Y, journalName=BMJ Open, refType=null, unstructuredReference=
WANG T,
WANG X,
YAO Y,
et al. Association of plasma apolipoproteins and levels of inflammation-related factors with different stages of Alzheimer’s disease:a cross-sectional study[J].
BMJ Open,
2022,
12(3):e054347., articleTitle=Association of plasma apolipoproteins and levels of inflammation-related factors with different stages of Alzheimer’s disease:a cross-sectional study, refAbstract=null), Reference(id=1322190411960013348, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1001/jama.2023.3196, pmid=null, pmcid=null, year=2023, volume=329, issue=10, pageStart=969, pageEnd=null, url=null, language=null, rfNumber=38, rfOrder=38, authorNames=HARRIS E, journalName=JAMA, refType=null, unstructuredReference=
HARRIS E. Blood Biomarker Helps Distinguish Vascular Dementia[J].
JAMA,
2023,
329(10):969., articleTitle=Blood Biomarker Helps Distinguish Vascular Dementia, refAbstract=null), Reference(id=1322190412077453861, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1186/s40478-024-01873-1, pmid=null, pmcid=null, year=2024, volume=12, issue=null, pageStart=167, pageEnd=null, url=null, language=null, rfNumber=39, rfOrder=39, authorNames=WANG Z, GILLILAND T, KIM HJ, journalName=Acta Neuropathol Commun, refType=null, unstructuredReference=
WANG Z,
GILLILAND T,
KIM HJ,
et al. A minimally invasive biomarker for sensitive and accurate diagnosis of Parkinson’s disease[J].
Acta Neuropathol Commun,
2024,
12:167., articleTitle=A minimally invasive biomarker for sensitive and accurate diagnosis of Parkinson’s disease, refAbstract=null), Reference(id=1322190412169728550, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1016/j.envres.2023.115705, pmid=null, pmcid=null, year=2023, volume=227, issue=null, pageStart=115705, pageEnd=null, url=null, language=null, rfNumber=40, rfOrder=40, authorNames=PISHBIN E, SADRI F, DEHGHAN A, journalName=Environ Res, refType=null, unstructuredReference=
PISHBIN E,
SADRI F,
DEHGHAN A,
et al. Recent advances in isolation and detection of exosomal microRNAs related to Alzheimer’s disease[J].
Environ Res,
2023,
227:115705., articleTitle=Recent advances in isolation and detection of exosomal microRNAs related to Alzheimer’s disease, refAbstract=null), Reference(id=1322190412232643111, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1126/sciadv.abm3088, pmid=null, pmcid=null, year=2024, volume=10, issue=5, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=41, rfOrder=41, authorNames=HU S, ZHANG L, SU Y, journalName=Sci Adv, refType=null, unstructuredReference=
HU S,
ZHANG L,
SU Y,
et al. Sensitive detection of multiple blood biomarkers via immunomagnetic exosomal PCR for the diagnosis of Alzheimer’s disease[J].
Sci Adv,
2024,
10(5):eabm3088., articleTitle=Sensitive detection of multiple blood biomarkers via immunomagnetic exosomal PCR for the diagnosis of Alzheimer’s disease, refAbstract=null), Reference(id=1322190412308140584, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1002/alz.14087, pmid=null, pmcid=null, year=2024, volume=20, issue=5, pageStart=6094, pageEnd=6106, url=null, language=null, rfNumber=42, rfOrder=42, authorNames=DAYARATHNA T, ROSEBOROUGH AD, GOMES J, journalName=Alzheimers Dement, refType=null, unstructuredReference=
DAYARATHNA T,
ROSEBOROUGH AD,
GOMES J,
et al. Nanoscale flow cytometry-based quantification of blood-based extracellular vesicle biomarkers distinguishes MCI and Alzheimer’s disease[J].
Alzheimers Dement,
2024,
20(5):6094-6106., articleTitle=Nanoscale flow cytometry-based quantification of blood-based extracellular vesicle biomarkers distinguishes MCI and Alzheimer’s disease, refAbstract=null), Reference(id=1322190412379443753, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1007/s11011-024-01431-7, pmid=null, pmcid=null, year=2024, volume=40, issue=1, pageStart=44, pageEnd=null, url=null, language=null, rfNumber=43, rfOrder=43, authorNames=FATTAHI F, ASADI MR, ABED S, journalName=Metab Brain Dis, refType=null, unstructuredReference=
FATTAHI F,
ASADI MR,
ABED S,
et al. Blood-based microRNAs as the potential biomarkers for Alzheimer’s disease:evidence from a systematic review[J].
Metab Brain Dis,
2024,
40(1):44., articleTitle=Blood-based microRNAs as the potential biomarkers for Alzheimer’s disease:evidence from a systematic review, refAbstract=null), Reference(id=1322190412496884266, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1186/s13195-022-01113-5, pmid=null, pmcid=null, year=2022, volume=14, issue=null, pageStart=174, pageEnd=null, url=null, language=null, rfNumber=44, rfOrder=44, authorNames=DAMMER EB, PING L, DUONG DM, journalName=Alzheimers Res Ther, refType=null, unstructuredReference=
DAMMER EB,
PING L,
DUONG DM,
et al. Multi-platform proteomic analysis of Alzheimer’s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome[J].
Alzheimers Res Ther,
2022,
14:174., articleTitle=Multi-platform proteomic analysis of Alzheimer’s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome, refAbstract=null), Reference(id=1322190412593353259, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1038/s41562-024-01924-6, pmid=null, pmcid=null, year=2024, volume=8, issue=11, pageStart=2047, pageEnd=2066, url=null, language=null, rfNumber=45, rfOrder=45, authorNames=GUO Y, CHEN S-D, YOU J, journalName=Nat Hum Behav, refType=null, unstructuredReference=
GUO Y,
CHEN S-D,
YOU J,
et al. Multiplex cerebrospinal fluid proteomics identifies biomarkers for diagnosis and prediction of Alzheimer’s disease[J].
Nat Hum Behav,
2024,
8(11):2047-2066., articleTitle=Multiplex cerebrospinal fluid proteomics identifies biomarkers for diagnosis and prediction of Alzheimer’s disease, refAbstract=null), Reference(id=1322190412673045036, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1038/s41591-023-02476-4, pmid=null, pmcid=null, year=2023, volume=29, issue=12, pageStart=1979, pageEnd=1988, url=null, language=null, rfNumber=46, rfOrder=46, authorNames=JOHNSON ECB, BIAN S, HAQUE RU, journalName=Nat Med, refType=null, unstructuredReference=
JOHNSON ECB,
BIAN S,
HAQUE RU,
et al. Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease[J].
Nat Med,
2023,
29(12):1979-1988., articleTitle=Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease, refAbstract=null), Reference(id=1322190412765319726, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1038/s41593-024-01737-w, pmid=null, pmcid=null, year=2024, volume=27, issue=12, pageStart=1880, pageEnd=1891, url=null, language=null, rfNumber=47, rfOrder=47, authorNames=PICHET BINETTE A, GAITERI C, WENNSTRÖM M, journalName=Nat Neurosci, refType=null, unstructuredReference=
PICHET BINETTE A,
GAITERI C,
WENNSTRÖM M,
et al. Proteomic changes in Alzheimer’s disease associated with progressive Aβ plaque and tau tangle pathologies[J].
Nat Neurosci,
2024,
27(12):1880-1891., articleTitle=Proteomic changes in Alzheimer’s disease associated with progressive Aβ plaque and tau tangle pathologies, refAbstract=null), Reference(id=1322190412853400111, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.3390/biom14050512, pmid=null, pmcid=null, year=2024, volume=14, issue=5, pageStart=512, pageEnd=null, url=null, language=null, rfNumber=48, rfOrder=48, authorNames=KRÜGER L, BISKUP K, SCHIPKE CG, journalName=Biomolecules, refType=null, unstructuredReference=
KRÜGER L,
BISKUP K,
SCHIPKE CG,
et al. The Cerebrospinal Fluid Free-Glycans Hex1 and HexNAc1Hex1Neu5Ac1 as Potential Biomarkers of Alzheimer’s Disease[J].
Biomolecules,
2024,
14(5):512., articleTitle=The Cerebrospinal Fluid Free-Glycans Hex1 and HexNAc1Hex1Neu5Ac1 as Potential Biomarkers of Alzheimer’s Disease, refAbstract=null), Reference(id=1322190412920508976, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1038/s41582-021-00520-w, pmid=null, pmcid=null, year=2021, volume=17, issue=9, pageStart=580, pageEnd=589, url=null, language=null, rfNumber=49, rfOrder=49, authorNames=HAMPEL H, CUMMINGS J, BLENNOW K, journalName=Nat Rev Neurol, refType=null, unstructuredReference=
HAMPEL H,
CUMMINGS J,
BLENNOW K,
et al. Developing the ATX(N) classification for use across the Alzheimer disease continuum[J].
Nat Rev Neurol,
2021,
17(9):580-589., articleTitle=Developing the ATX(N) classification for use across the Alzheimer disease continuum, refAbstract=null), Reference(id=1322190413012783665, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1007/s12264-022-00836-7, pmid=null, pmcid=null, year=2022, volume=38, issue=5, pageStart=677, pageEnd=691, url=null, language=null, rfNumber=50, rfOrder=50, authorNames=HUANG S, WANG Y-J, GUO J, journalName=Neurosci Bull, refType=null, unstructuredReference=
HUANG S,
WANG Y-J,
GUO J,
et al. Biofluid Biomarkers of Alzheimer’s Disease:Progress,Problems,and Perspectives[J].
Neurosci Bull,
2022,
38(5):677-691., articleTitle=Biofluid Biomarkers of Alzheimer’s Disease:Progress,Problems,and Perspectives, refAbstract=null), Reference(id=1322190414682116658, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1016/S1474-4422(21)00214-3, pmid=null, pmcid=null, year=2021, volume=20, issue=9, pageStart=739, pageEnd=752, url=null, language=null, rfNumber=51, rfOrder=51, authorNames=THIJSSEN EH, LA JOIE R, STROM A, journalName=Lancet Neurol, refType=null, unstructuredReference=
THIJSSEN EH,
LA JOIE R,
STROM A,
et al. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer’s disease and frontotemporal lobar degeneration:a retrospective diagnostic performance study[J].
Lancet Neurol,
2021,
20(9):739-752., articleTitle=Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer’s disease and frontotemporal lobar degeneration:a retrospective diagnostic performance study, refAbstract=null), Reference(id=1322190414757614131, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1001/jamaneurol.2022.4485, pmid=null, pmcid=null, year=2023, volume=80, issue=2, pageStart=188, pageEnd=199, url=null, language=null, rfNumber=52, rfOrder=52, authorNames=THERRIAULT J, VERMEIREN M, SERVAES S, journalName=JAMA Neurol, refType=null, unstructuredReference=
THERRIAULT J,
VERMEIREN M,
SERVAES S,
et al. Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography[J].
JAMA Neurol,
2023,
80(2):188-199., articleTitle=Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography, refAbstract=null), Reference(id=1322190414841500212, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1038/s41467-024-46876-7, pmid=null, pmcid=null, year=2024, volume=15, issue=null, pageStart=2615, pageEnd=null, url=null, language=null, rfNumber=53, rfOrder=53, authorNames=KAC PR, GONZÁLEZ-ORTIZ F, EMERŠIČ A, journalName=Nat Commun, refType=null, unstructuredReference=KAC PR,
GONZÁLEZ-ORTIZ F,
EMERŠIČ A,
et al. Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology[J].
Nat Commun,
2024,
15:2615., articleTitle=Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology, refAbstract=null), Reference(id=1322190414904414773, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1002/alz.14430, pmid=null, pmcid=null, year=2024, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=54, rfOrder=54, authorNames=OLVERA-ROJAS M, SEWELL KR, KARIKARI TK, journalName=Alzheimers Dement, refType=null, unstructuredReference=
OLVERA-ROJAS M,
SEWELL KR,
KARIKARI TK,
et al. Influence of medical conditions on the diagnostic accuracy of plasma p-tau217 and p-tau217/Aβ42[J].
Alzheimers Dement,
2024., articleTitle=Influence of medical conditions on the diagnostic accuracy of plasma p-tau217 and p-tau217/Aβ42, refAbstract=null), Reference(id=1322190414971523638, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1186/s13195-024-01469-w, pmid=null, pmcid=null, year=2024, volume=16, issue=null, pageStart=115, pageEnd=null, url=null, language=null, rfNumber=55, rfOrder=55, authorNames=NIIMI Y, JANELIDZE S, SATO K, journalName=Alzheimers Res Ther, refType=null, unstructuredReference=
NIIMI Y,
JANELIDZE S,
SATO K,
et al. Combining plasma Aβ and p-tau217 improves detection of brain amyloid in non-demented elderly[J].
Alzheimers Res Ther,
2024,
16:115., articleTitle=Combining plasma Aβ and p-tau217 improves detection of brain amyloid in non-demented elderly, refAbstract=null), Reference(id=1322190415034438199, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1002/alz.13676, pmid=null, pmcid=null, year=2024, volume=20, issue=10, pageStart=2000, pageEnd=2015, url=null, language=null, rfNumber=56, rfOrder=56, authorNames=JIANG Y, UHM H, IP FC, journalName=Alzheimers Dement, refType=null, unstructuredReference=
JIANG Y,UHM H,IP FC,
et al. A blood-based multi-pathway biomarker assay for early detection and staging of Alzheimer’s disease across ethnic groups[J].
Alzheimers Dement,
2024,
20(10):2000-2015., articleTitle=A blood-based multi-pathway biomarker assay for early detection and staging of Alzheimer’s disease across ethnic groups, refAbstract=null), Reference(id=1322190415109935672, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1212/WNL.0000000000201479, pmid=null, pmcid=null, year=2023, volume=100, issue=2, pageStart=e473, pageEnd=e484, url=null, language=null, rfNumber=57, rfOrder=57, authorNames=PLANCHE V, BOUTELOUP V, PELLEGRIN I, journalName=Neurology, refType=null, unstructuredReference=
PLANCHE V,
BOUTELOUP V,
PELLEGRIN I,
et al. Validity and Performance of Blood Biomarkers for Alzheimer Disease to Predict Dementia Risk in a Large Clinic-Based Cohort[J].
Neurology,
2023,
100(2):e473-e484., articleTitle=Validity and Performance of Blood Biomarkers for Alzheimer Disease to Predict Dementia Risk in a Large Clinic-Based Cohort, refAbstract=null), Reference(id=1322190415189627449, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1001/jamaneurol.2025.0142, pmid=null, pmcid=null, year=2025, volume=82, issue=4, pageStart=506, pageEnd=515, url=null, language=null, rfNumber=58, rfOrder=58, authorNames=BOUTELOUP V, VILLAIN N, VIDAL JS, journalName=JAMA Neurol, refType=null, unstructuredReference=
BOUTELOUP V,
VILLAIN N,
VIDAL JS,
et al. Cognitive Phenotyping and Interpretation of Alzheimer Blood Biomarkers[J].
JAMA Neurol,
2025,
82(4):506-515., articleTitle=Cognitive Phenotyping and Interpretation of Alzheimer Blood Biomarkers, refAbstract=null), Reference(id=1322190415269319226, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1002/alz.12792, pmid=null, pmcid=null, year=2023, volume=19, issue=8, pageStart=1428, pageEnd=1439, url=null, language=null, rfNumber=59, rfOrder=59, authorNames=KATABATHULA S, DAVIS PB, XU R, journalName=Alzheimers Dement, refType=null, unstructuredReference=
KATABATHULA S,
DAVIS PB,
XU R,
et al. Comorbidity-driven multi-modal subtype analysis in mild cognitive impairment of Alzheimer’s disease[J].
Alzheimers Dement,
2023,
19(8):1428-1439., articleTitle=Comorbidity-driven multi-modal subtype analysis in mild cognitive impairment of Alzheimer’s disease, refAbstract=null), Reference(id=1322190415332233787, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1016/j.scib.2023.07.009, pmid=null, pmcid=null, year=2023, volume=68, issue=15, pageStart=1800, pageEnd=1808, url=null, language=null, rfNumber=60, rfOrder=60, authorNames=GAO F, DAI L, WANG Q, journalName=Sci Bull (Beijing), refType=null, unstructuredReference=
GAO F,
DAI L,
WANG Q,
et al. Blood-based biomarkers for Alzheimer’s disease:a multicenter-based cross-sectional and longitudinal study in China[J].
Sci Bull (Beijing),
2023,
68(15):1800-1808., articleTitle=Blood-based biomarkers for Alzheimer’s disease:a multicenter-based cross-sectional and longitudinal study in China, refAbstract=null), Reference(id=1322190415483228732, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1038/s41398-022-02016-7, pmid=null, pmcid=null, year=2022, volume=12, issue=null, pageStart=252, pageEnd=null, url=null, language=null, rfNumber=61, rfOrder=61, authorNames=FAN D Y, JIAN J M, HUANG S, journalName=Transl Psychiatry, refType=null, unstructuredReference=
FAN D Y,
JIAN J M,
HUANG S,
et al. Establishment of combined diagnostic models of Alzheimer’s disease in a Chinese cohort:the Chongqing Ageing & Dementia Study (CADS)[J].
Transl Psychiatry,
2022,
12:252., articleTitle=Establishment of combined diagnostic models of Alzheimer’s disease in a Chinese cohort:the Chongqing Ageing & Dementia Study (CADS), refAbstract=null), Reference(id=1322190415562920509, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1093/braincomms/fcaf004, pmid=null, pmcid=null, year=2025, volume=7, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=62, rfOrder=62, authorNames=WANG Y-T, ASHTON NJ, THERRIAULT J, journalName=Brain Commun, refType=null, unstructuredReference=
WANG Y-T,
ASHTON NJ,
THERRIAULT J,
et al. Identify biological Alzheimer’s disease using a novel nucleic acid-linked protein immunoassay[J].
Brain Commun,
2025,
7:fcaf004., articleTitle=Identify biological Alzheimer’s disease using a novel nucleic acid-linked protein immunoassay, refAbstract=null), Reference(id=1322190415642612286, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1093/clinchem/hvac149, pmid=null, pmcid=null, year=2022, volume=68, issue=12, pageStart=1552, pageEnd=1563, url=null, language=null, rfNumber=63, rfOrder=63, authorNames=XIAO Z, WU W, MA X, journalName=Clin Chem, refType=null, unstructuredReference=
XIAO Z,
WU W,
MA X,
et al. Plasma Aβ42/Aβ40 and p-tau181 Predict Long-Term Clinical Progression in a Cohort with Amnestic Mild Cognitive Impairment[J].
Clin Chem,
2022,
68(12):1552-1563., articleTitle=Plasma Aβ42/Aβ40 and p-tau181 Predict Long-Term Clinical Progression in a Cohort with Amnestic Mild Cognitive Impairment, refAbstract=null), Reference(id=1322190415864910399, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.3390/ijms232415670, pmid=null, pmcid=null, year=2022, volume=23, issue=24, pageStart=15670, pageEnd=null, url=null, language=null, rfNumber=64, rfOrder=64, authorNames=CHO HJ, SCHULZ P, VENKATARAMAN L, journalName=Int J Mol Sci, refType=null, unstructuredReference=
CHO HJ,
SCHULZ P,
VENKATARAMAN L,
et al. Sex-Specific Multiparameter Blood Test for the Early Diagnosis of Alzheimer’s Disease[J].
Int J Mol Sci,
2022,
23(24):15670., articleTitle=Sex-Specific Multiparameter Blood Test for the Early Diagnosis of Alzheimer’s Disease, refAbstract=null), Reference(id=1322190415944602176, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1001/jamaneurol.2022.3392, pmid=null, pmcid=null, year=2022, volume=79, issue=11, pageStart=1250, pageEnd=1259, url=null, language=null, rfNumber=65, rfOrder=65, authorNames=PONTECORVO MJ, LU M, BURNHAM SC, journalName=JAMA Neurol, refType=null, unstructuredReference=
PONTECORVO MJ,
LU M,
BURNHAM SC,
et al. Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease:A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical Trial[J].
JAMA Neurol,
2022,
79(11):1250-1259., articleTitle=Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease:A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical Trial, refAbstract=null), Reference(id=1322190416024293953, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1002/alz. 12510, pmid=null, pmcid=null, year=2022, volume=18, issue=8, pageStart=1484, pageEnd=1497, url=null, language=null, rfNumber=66, rfOrder=66, authorNames=VERBERK IMW, MISDORP EO, KOELEWIJN J, journalName=Alzheimers Dement, refType=null, unstructuredReference=
VERBERK IMW,
MISDORP EO,
KOELEWIJN J,
et al. Characterization of pre-analytical sample handling effects on a panel of Alzheimer’s disease-related blood-based biomarkers:Results from the Standardization of Alzheimer’s Blood Biomarkers (SABB) working group[J].
Alzheimers Dement,
2022,
18(8):1484-1497., articleTitle=Characterization of pre-analytical sample handling effects on a panel of Alzheimer’s disease-related blood-based biomarkers:Results from the Standardization of Alzheimer’s Blood Biomarkers (SABB) working group, refAbstract=null), Reference(id=1322190416271757890, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1016/j.jalz.2014.08.099, pmid=null, pmcid=null, year=2015, volume=11, issue=5, pageStart=549, pageEnd=560, url=null, language=null, rfNumber=67, rfOrder=67, authorNames=O’BRYANT SE, GUPTA V, HENRIKSEN K, journalName=Alzheimers Dement, refType=null, unstructuredReference=
O’BRYANT SE,
GUPTA V,
HENRIKSEN K,
et al. Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer’s disease research[J].
Alzheimers Dement,
2015,
11(5):549-560., articleTitle=Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer’s disease research, refAbstract=null), Reference(id=1322190416397587011, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1016/j.dadm.2019.02.002, pmid=null, pmcid=null, year=2019, volume=11, issue=null, pageStart=291, pageEnd=300, url=null, language=null, rfNumber=68, rfOrder=68, authorNames=RÓZGA M, BITTNER T, BATRLA R, journalName=Alzheimers Dement (Amst), refType=null, unstructuredReference=
RÓZGA M,
BITTNER T,
BATRLA R,
et al. Preanalytical sample handling recommendations for Alzheimer’s disease plasma biomarkers[J].
Alzheimers Dement (Amst),
2019,
11:291-300., articleTitle=Preanalytical sample handling recommendations for Alzheimer’s disease plasma biomarkers, refAbstract=null), Reference(id=1322190416468890180, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.3760/cma.j.cn112137-20240523-01174, pmid=null, pmcid=null, year=2024, volume=104, issue=35, pageStart=3292, pageEnd=3306, url=null, language=null, rfNumber=69, rfOrder=69, authorNames=国家卫生健康委能力建设和继续教育中心, 中国神经科学学会, 衰老标志物联合体, journalName=中华医学杂志, refType=null, unstructuredReference=国家卫生健康委能力建设和继续教育中心,中国神经科学学会,衰老标志物联合体,
等. 阿尔茨海默病体液标志物临床应用中国指南(2024版).
中华医学杂志,
2024,
104(35):3292-3306., articleTitle=阿尔茨海默病体液标志物临床应用中国指南(2024版), refAbstract=null), Reference(id=1322190416707965510, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.3760/cma.j.cn112137-20240523-01174, pmid=null, pmcid=null, year=2024, volume=104, issue=35, pageStart=3292, pageEnd=3306, url=null, language=null, rfNumber=69, rfOrder=70, authorNames=National Health Commission Capacity Building and Continuing Education Center, Chinese Neuroscience Society, Aging Biomarker Consortium, journalName=National Medical Journal of china, refType=null, unstructuredReference=National Health Commission Capacity Building and Continuing Education Center,Chinese Neuroscience Society,Aging Biomarker Consortium,
et al. Chinese guideline for clinical application of fluid biomarkers for Alzheimer′s disease(2024 edition).
National Medical Journal of china,
2024,
104(35):3292-3306., articleTitle=Chinese guideline for clinical application of fluid biomarkers for Alzheimer′s disease(2024 edition), refAbstract=null), Reference(id=1322190416804434503, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1038/nrneurol.2017.111, pmid=null, pmcid=null, year=2017, volume=13, issue=11, pageStart=612, pageEnd=623, url=null, language=null, rfNumber=70, rfOrder=71, authorNames=WANG J, GU B J, MASTERS C L, journalName=Nat Rev Neurol, refType=null, unstructuredReference=
WANG J,
GU B J,
MASTERS C L,
et al. A systemic view of Alzheimer disease - insights from amyloid-β metabolism beyond the brain[J].
Nat Rev Neurol,
2017,
13(11):612-623., articleTitle=A systemic view of Alzheimer disease - insights from amyloid-β metabolism beyond the brain, refAbstract=null), Reference(id=1322190416884126280, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1007/s40120-019-00167-2, pmid=null, pmcid=null, year=2019, volume=8, issue=1, pageStart=95, pageEnd=111, url=null, language=null, rfNumber=71, rfOrder=72, authorNames=LUE L F, KUO Y M, SABBAGH M, journalName=Neurol Ther, refType=null, unstructuredReference=
LUE L F,
KUO Y M,
SABBAGH M. Advance in Plasma AD Core Biomarker Development:Current Findings from Immunomagnetic Reduction-Based SQUID Technology[J].
Neurol Ther,
2019,
8(1):95-111., articleTitle=Advance in Plasma AD Core Biomarker Development:Current Findings from Immunomagnetic Reduction-Based SQUID Technology, refAbstract=null), Reference(id=1322190417123201609, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1038/nature25456, pmid=null, pmcid=null, year=2018, volume=554, issue=7691, pageStart=249, pageEnd=254, url=null, language=null, rfNumber=72, rfOrder=73, authorNames=NAKAMURA A, KANEKO N, VILLEMAGNE VL, journalName=Nature, refType=null, unstructuredReference=
NAKAMURA A,
KANEKO N,
VILLEMAGNE VL,
et al. High-performance plasma amyloid-β biomarkers for Alzheimer’s disease[J].
Nature,
2018,
554(7691):249-254., articleTitle=High-performance plasma amyloid-β biomarkers for Alzheimer’s disease, refAbstract=null), Reference(id=1322190417223864906, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1038/s41591-020-0781-z, pmid=null, pmcid=null, year=2020, volume=26, issue=3, pageStart=398, pageEnd=407, url=null, language=null, rfNumber=73, rfOrder=74, authorNames=BARTHÉLEMY NR, LI Y, JOSEPH-MATHURIN N, journalName=Nat Med, refType=null, unstructuredReference=
BARTHÉLEMY NR,
LI Y,
JOSEPH-MATHURIN N,
et al. A soluble phosphorylated tau signature links tau,amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease[J].
Nat Med,
2020,
26(3):398-407., articleTitle=A soluble phosphorylated tau signature links tau,amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease, refAbstract=null), Reference(id=1322190417316139595, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1016/j.cca.2021.05.011, pmid=null, pmcid=null, year=2021, volume=519, issue=null, pageStart=267, pageEnd=275, url=null, language=null, rfNumber=74, rfOrder=75, authorNames=KIRMESS K M, MEYER M R, HOLUBASCH M S, journalName=Clin Chim Acta, refType=null, unstructuredReference=
KIRMESS K M,
MEYER M R,
HOLUBASCH M S,
et al. The PrecivityADTM test:Accurate and reliable LC-MS/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosis[J].
Clin Chim Acta,
2021,
519:267-275., articleTitle=The PrecivityADTM test:Accurate and reliable LC-MS/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosis, refAbstract=null), Reference(id=1322190417571992140, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1016/j.jalz.2017.06.2266, pmid=null, pmcid=null, year=2017, volume=13, issue=8, pageStart=841, pageEnd=849, url=null, language=null, rfNumber=75, rfOrder=76, authorNames=OVOD V, RAMSEY KN, MAWUENYEGA KG, journalName=Alzheimers Dement, refType=null, unstructuredReference=
OVOD V,
RAMSEY KN,
MAWUENYEGA KG,
et al. Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis[J].
Alzheimers Dement,
2017,
13(8):841-849., articleTitle=Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis, refAbstract=null), Reference(id=1322190419170021965, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1186/s13195-020-00728-w, pmid=null, pmcid=null, year=2020, volume=12, issue=null, pageStart=162, pageEnd=null, url=null, language=null, rfNumber=76, rfOrder=77, authorNames=DE MEYER S, SCHAEVERBEKE JM, VERBERK IMW, journalName=Alzheimers Res Ther, refType=null, unstructuredReference=
DE MEYER S,
SCHAEVERBEKE JM,
VERBERK IMW,
et al. Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis[J].
Alzheimers Res Ther,
2020,
12:162., articleTitle=Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis, refAbstract=null), Reference(id=1322190419291656782, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1001/jamaneurol.2019.1632, pmid=null, pmcid=null, year=2019, volume=76, issue=9, pageStart=1060, pageEnd=1069, url=null, language=null, rfNumber=77, rfOrder=78, authorNames=PALMQVIST S, JANELIDZE S, STOMRUD E, journalName=JAMA Neurol, refType=null, unstructuredReference=
PALMQVIST S,
JANELIDZE S,
STOMRUD E,
et al. Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status[J].
JAMA Neurol,
2019,
76(9):1060-1069., articleTitle=Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status, refAbstract=null), Reference(id=1322190419362959951, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1093/brain/awad042, pmid=null, pmcid=null, year=2023, volume=146, issue=6, pageStart=2029, pageEnd=2044, url=null, language=null, rfNumber=78, rfOrder=79, authorNames=JACK CR, WISTE HJ, ALGECIRAS-SCHIMNICH A, journalName=Brain, refType=null, unstructuredReference=
JACK CR,
WISTE HJ,
ALGECIRAS-SCHIMNICH A,
et al. Predicting amyloid PET and tau PET stages with plasma biomarkers[J].
Brain,
2023,
146(6):2029-2044., articleTitle=Predicting amyloid PET and tau PET stages with plasma biomarkers, refAbstract=null), Reference(id=1322190419463623248, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1186/s13195-022-01116-2, pmid=null, pmcid=null, year=2022, volume=14, issue=null, pageStart=172, pageEnd=null, url=null, language=null, rfNumber=79, rfOrder=80, authorNames=WILSON EN, YOUNG CB, RAMOS BENITEZ J, journalName=Alzheimers Res Ther, refType=null, unstructuredReference=
WILSON EN,
YOUNG CB,
RAMOS BENITEZ J,
et al. Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer’s disease[J].
Alzheimers Res Ther,
2022,
14:172., articleTitle=Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer’s disease, refAbstract=null), Reference(id=1322190419623006801, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1038/s41467-023-42834-x, pmid=null, pmcid=null, year=2023, volume=14, issue=null, pageStart=7238, pageEnd=null, url=null, language=null, rfNumber=80, rfOrder=81, authorNames=FENG W, BEER JC, HAO Q, journalName=Nat Commun, refType=null, unstructuredReference=
FENG W,
BEER JC,
HAO Q,
et al. NULISA:a proteomic liquid biopsy platform with attomolar sensitivity and high multiplexing[J].
Nat Commun,
2023,
14:7238., articleTitle=NULISA:a proteomic liquid biopsy platform with attomolar sensitivity and high multiplexing, refAbstract=null), Reference(id=1322190419685921362, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1016/j.eclinm.2025.103142, pmid=null, pmcid=null, year=2025, volume=81, issue=null, pageStart=103142, pageEnd=null, url=null, language=null, rfNumber=81, rfOrder=82, authorNames=JIAO B, OUYANG Z, XIAO X, journalName=EClinicalMedicine, refType=null, unstructuredReference=
JIAO B,
OUYANG Z,
XIAO X,
et al. Development and validation of machine learning models with blood-based digital biomarkers for Alzheimer’s disease diagnosis:a multicohort diagnostic study[J].
EClinicalMedicine,
2025,
81:103142., articleTitle=Development and validation of machine learning models with blood-based digital biomarkers for Alzheimer’s disease diagnosis:a multicohort diagnostic study, refAbstract=null), Reference(id=1322190419761418835, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1177/138728772 41301802, pmid=null, pmcid=null, year=2024, volume=null, issue=null, pageStart=13872877241301802, pageEnd=null, url=null, language=null, rfNumber=82, rfOrder=83, authorNames=WEISS JN, journalName=J Alzheimers Dis, refType=null, unstructuredReference=
WEISS JN. Dynamic light scattering of the eye in the diagnosis of Alzheimer’s disease[J].
J Alzheimers Dis,
2024:13872877241301802., articleTitle=Dynamic light scattering of the eye in the diagnosis of Alzheimer’s disease, refAbstract=null), Reference(id=1322190419836916308, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1021/acs.analchem.4c05865, pmid=null, pmcid=null, year=2024, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=83, rfOrder=84, authorNames=WANG Y, ZHOU J, CHEN X, journalName=Anal Chem, refType=null, unstructuredReference=
WANG Y,
ZHOU J,
CHEN X,
et al. Blood Screening of Femtomole Level Multiple Alzheimer’s Disease Biomarkers by Metal Isotopic DNA Walkers[J].
Anal Chem,
2024., articleTitle=Blood Screening of Femtomole Level Multiple Alzheimer’s Disease Biomarkers by Metal Isotopic DNA Walkers, refAbstract=null), Reference(id=1322190420046631509, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1111/aji.12512, pmid=null, pmcid=null, year=2016, volume=75, issue=6, pageStart=678, pageEnd=693, url=null, language=null, rfNumber=84, rfOrder=85, authorNames=ALDO P, MARUSOV G, SVANCARA D, journalName=Am J Reprod Immunol, refType=null, unstructuredReference=
ALDO P,
MARUSOV G,
SVANCARA D,
et al. Simple Plex(TM):A Novel Multi-Analyte,Automated Microfluidic Immunoassay Platform for the Detection of Human and Mouse Cytokines and Chemokines[J].
Am J Reprod Immunol,
2016,
75(6):678-693., articleTitle=Simple Plex(TM):A Novel Multi-Analyte,Automated Microfluidic Immunoassay Platform for the Detection of Human and Mouse Cytokines and Chemokines, refAbstract=null), Reference(id=1322190420260541014, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1007/s00604-024-06764-9, pmid=null, pmcid=null, year=2024, volume=191, issue=null, pageStart=700, pageEnd=null, url=null, language=null, rfNumber=85, rfOrder=86, authorNames=GŁOWACZ K, TOKARSKA W, OLECHOWSKA A, journalName=Mikrochim Acta, refType=null, unstructuredReference=
GŁOWACZ K,
TOKARSKA W,
OLECHOWSKA A,
et al. Tuning multispectral fluorescence quantum dot-based identification of short-length amyloid β peptides by applying Cu(II) ions[J].
Mikrochim Acta,
2024,
191:700., articleTitle=Tuning multispectral fluorescence quantum dot-based identification of short-length amyloid β peptides by applying Cu(II) ions, refAbstract=null), Reference(id=1322190420348621399, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.3390/ijms252212211, pmid=null, pmcid=null, year=2024, volume=25, issue=22, pageStart=12211, pageEnd=null, url=null, language=null, rfNumber=86, rfOrder=87, authorNames=ALHARTHI F, APACHIGAWO I, SOLANKI D, journalName=Int J Mol Sci, refType=null, unstructuredReference=
ALHARTHI F,
APACHIGAWO I,
SOLANKI D,
et al. Dual Photonics Probing of Nano- to Submicron-Scale Structural Alterations in Human Brain Tissues/Cells and Chromatin/DNA with the Progression of Alzheimer’s Disease[J].
Int J Mol Sci,
2024,
25(22):12211., articleTitle=Dual Photonics Probing of Nano- to Submicron-Scale Structural Alterations in Human Brain Tissues/Cells and Chromatin/DNA with the Progression of Alzheimer’s Disease, refAbstract=null), Reference(id=1322190420411535960, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1002/alz.14319, pmid=null, pmcid=null, year=2024, volume=20, issue=8, pageStart=8700, pageEnd=8714, url=null, language=null, rfNumber=87, rfOrder=88, authorNames=NGAI T, WILLETT J, WAQAS M, journalName=Alzheimers Dement, refType=null, unstructuredReference=
NGAI T,
WILLETT J,
WAQAS M,
et al. Assessing polyomic risk to predict Alzheimer’s disease using a machine learning model[J].
Alzheimers Dement,
2024,
20(8):8700-8714., articleTitle=Assessing polyomic risk to predict Alzheimer’s disease using a machine learning model, refAbstract=null), Reference(id=1322190420566725209, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1002/alz.14600, pmid=null, pmcid=null, year=2025, volume=21, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=88, rfOrder=89, authorNames=KARLSSON L, VOGEL J, ARVIDSSON I, journalName=Alzheimers Dement, refType=null, unstructuredReference=
KARLSSON L,
VOGEL J,
ARVIDSSON I,
et al. Machine learning prediction of tau-PET in Alzheimer’s disease using plasma,MRI,and clinical data[J].
Alzheimers Dement,
2025,
21:e14600., articleTitle=Machine learning prediction of tau-PET in Alzheimer’s disease using plasma,MRI,and clinical data, refAbstract=null), Reference(id=1322190420663194202, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1186/s13195-024-01651-0, pmid=null, pmcid=null, year=2025, volume=17, issue=null, pageStart=3, pageEnd=null, url=null, language=null, rfNumber=89, rfOrder=90, authorNames=HUANG Y-L, T-H TSAI, SHEN Z-Q, journalName=Alzheimers Res Ther, refType=null, unstructuredReference=
HUANG Y-L,
T-H TSAI,
SHEN Z-Q,
et al. Transcriptomic predictors of rapid progression from mild cognitive impairment to Alzheimer’s disease[J].
Alzheimers Res Ther,
2025,
17:3., articleTitle=Transcriptomic predictors of rapid progression from mild cognitive impairment to Alzheimer’s disease, refAbstract=null), Reference(id=1322190420742885979, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, doi=10.1002/alz.14230, pmid=null, pmcid=null, year=2024, volume=20, issue=8, pageStart=7698, pageEnd=7714, url=null, language=null, rfNumber=90, rfOrder=91, authorNames=LIU S, PARK T, KRÜGER DM, journalName=Alzheimers Dement, refType=null, unstructuredReference=
LIU S,
PARK T,
KRÜGER DM,
et al. Plasma miRNAs across the Alzheimer’s disease continuum:Relationship to central biomarkers[J].
Alzheimers Dement,
2024,
20(8):7698-7714., articleTitle=Plasma miRNAs across the Alzheimer’s disease continuum:Relationship to central biomarkers, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1322190404154413536, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, xref=1, ext=[AuthorCompanyExt(id=1322190404162802145, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, companyId=1322190404154413536, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1Department of Neurology,Chongqing Key Laboratory of Aging and Brain Diseases,Army Medical Center of PLA/Daping Hospital of Third Military Medical University,Chongqing,China), AuthorCompanyExt(id=1322190404175385058, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, companyId=1322190404154413536, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1陆军特色医学中心(第三军医大学大坪医院)神经内科,衰老与脑疾病重庆市重点实验室,重庆)])], figs=[ArticleFig(id=1322190405635002872, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, language=EN, label=Table 1, caption=
Comparison of core blood biomarkers in AD
, figureFileSmall=null, figureFileBig=null, tableContent=
| 标志物 | 优点 | 缺点 |
|---|
| Aβ42/40 | AD特异性标志物 疾病上游标志物,早期诊断潜能 比值形式减小个体差异 | 黏性大,易受样本处理流程影响 血液中变化幅度小 易受外周代谢干扰 |
| pTau217 | 在AD与非AD人群变化幅度大 早期出现血液中可检测的改变 | 非AD特异性 温度敏感,检测变异较大 修饰态易受样本处理及检测流程影响 |
| pTau181 | 在AD与非AD人群变化幅度较大 早期改变 | 同pTau217缺点 修饰位点AD特异性较pTau217低 变化幅度低于pTau217 |
| pTau231 | 早期发生可检测的改变 (较其他pTau更早) 具有早期诊断潜能 | 同pTau217缺点 修饰位点AD特异性较pTau217低 变化幅度低于pTau217 |
| pTau217/Aβ42 | 在AD与非AD人群变化幅度最大 比值具备单一标志物优点 同时较单一标志物更稳定 | 同单一标志物缺点 检测成本增高 |
| pTau181/Aβ42 | 比值具备单一标志物优点 同时较单一标志物更稳定 | 同单一标志物缺点 检测成本增高 |
), ArticleFig(id=1322190405802775033, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, language=CN, label=表1, caption=
AD血液核心1标志物对比
, figureFileSmall=null, figureFileBig=null, tableContent=
| 标志物 | 优点 | 缺点 |
|---|
| Aβ42/40 | AD特异性标志物 疾病上游标志物,早期诊断潜能 比值形式减小个体差异 | 黏性大,易受样本处理流程影响 血液中变化幅度小 易受外周代谢干扰 |
| pTau217 | 在AD与非AD人群变化幅度大 早期出现血液中可检测的改变 | 非AD特异性 温度敏感,检测变异较大 修饰态易受样本处理及检测流程影响 |
| pTau181 | 在AD与非AD人群变化幅度较大 早期改变 | 同pTau217缺点 修饰位点AD特异性较pTau217低 变化幅度低于pTau217 |
| pTau231 | 早期发生可检测的改变 (较其他pTau更早) 具有早期诊断潜能 | 同pTau217缺点 修饰位点AD特异性较pTau217低 变化幅度低于pTau217 |
| pTau217/Aβ42 | 在AD与非AD人群变化幅度最大 比值具备单一标志物优点 同时较单一标志物更稳定 | 同单一标志物缺点 检测成本增高 |
| pTau181/Aβ42 | 比值具备单一标志物优点 同时较单一标志物更稳定 | 同单一标志物缺点 检测成本增高 |
), ArticleFig(id=1322190405878272506, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, language=EN, label=Table 2, caption=
Clinical application scenarios and efficacy of core blood biomarkers in AD
, figureFileSmall=null, figureFileBig=null, tableContent=
| 血液标志物 | 脑内病理相关性 | 临床应用场景及效能 |
|---|
| 疾病诊断 | 疾病分期 | 疗效监测 |
|---|
| Aβ42/40 | 中 | 中 | 差 | 中 |
| pTau217 | 高 | 高 | 中 | 较高 |
| pTau181 | 较高 | 高 | 中 | 较高 |
| pTau231 | 较高 | 中 | 中 | 中 |
| pTau217/Aβ42 | 高 | 高 | 较高 | 较高 |
| pTau181/Aβ42 | 较高 | 高 | 中 | 较高 |
), ArticleFig(id=1322190405966352891, tenantId=1146029695717560320, journalId=1319373162502258839, articleId=1322190401197429213, language=CN, label=表2, caption=
AD血液核心1标志物临床应用场景及效能
, figureFileSmall=null, figureFileBig=null, tableContent=
| 血液标志物 | 脑内病理相关性 | 临床应用场景及效能 |
|---|
| 疾病诊断 | 疾病分期 | 疗效监测 |
|---|
| Aβ42/40 | 中 | 中 | 差 | 中 |
| pTau217 | 高 | 高 | 中 | 较高 |
| pTau181 | 较高 | 高 | 中 | 较高 |
| pTau231 | 较高 | 中 | 中 | 中 |
| pTau217/Aβ42 | 高 | 高 | 较高 | 较高 |
| pTau181/Aβ42 | 较高 | 高 | 中 | 较高 |
)], attaches=null, journal=Journal(id=1319372634082869396, delFlag=0, nameCn=陆军军医大学学报, nameEn=Journal of Army Medical University, nameHistory1=null, nameHistory2=null, issn=2097-0927, eissn=null, cn=50-1223/R, coden=null, periodic=3, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=zdiTazv9TbsMJqLaCJ/k7A==, journalPrice=null, startedYear=null, abbrevIsoEn=Journal of Army Medical University, journalRemark=null, publicationField=null, createdTime=1792492548725, updatedTime=1792745216517, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=L, firstLetterEn=L, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=zdiTazv9TbsMJqLaCJ/k7A==, picEn=931BgeD2k9AIsc7QjHoQKg==, jcr=null, cjcr=null, exts=[JournalExt(id=1320432400862135101, language=CN, name=陆军军医大学学报, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792745216813, updatedTime=1792745216813, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://ljjydx.portal.founderss.cn, submissionEditorUrl=https://journal.ids.fzyun.cn, submissionReviewUrl=https://ljjydx.portal.founderss.cn, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320432400933438270, language=EN, name=Journal of Army Medical University, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792745216830, updatedTime=1792745216830, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://ljjydx.portal.founderss.cn, submissionEditorUrl=https://journal.ids.fzyun.cn, submissionReviewUrl=https://ljjydx.portal.founderss.cn, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319373162502258839, websiteList=[Website(id=1319376331821925278, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319373162502258839, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/ljjydxxb/CN, language=CN, createTime=1792493430333, createBy=18614031015, updateTime=1792493552921, updateBy=18614031015, name=陆军军医大学学报-中文, tplId=1146099689490845704, title=陆军军医大学学报, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1319376971570729589, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319376331821925278, code=articleTextType, value=kx, createTime=1792493582861, updateTime=1792493582861, creator=18614031015, updator=18614031015), WebsiteProps(id=1319376971549758066, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319376331821925278, code=banner, value=null, createTime=1792493582856, updateTime=1792493582856, creator=18614031015, updator=18614031015), WebsiteProps(id=1319376971591701112, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319376331821925278, code=grayFlag, value=0, createTime=1792493582866, updateTime=1792493582866, creator=18614031015, updator=18614031015), WebsiteProps(id=1319376971541369457, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319376331821925278, code=logo, value=https://castjournals.cast.org.cn/joweb/ljjydxxb/CN/file/pic?fileId=Mmvh7crXM7dcUwf9n9+ehg==, createTime=1792493582854, updateTime=1792493582854, creator=18614031015, updator=18614031015), WebsiteProps(id=1319376971608478330, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319376331821925278, code=minRunFlag, value=0, createTime=1792493582870, updateTime=1792493582870, creator=18614031015, updator=18614031015), WebsiteProps(id=1319376971562340980, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319376331821925278, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/ljjydxxb/CN/file/pic, createTime=1792493582859, updateTime=1792493582859, creator=18614031015, updator=18614031015), WebsiteProps(id=1319376971600089721, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319376331821925278, code=silenceFlag, value=0, createTime=1792493582868, updateTime=1792493582868, creator=18614031015, updator=18614031015), WebsiteProps(id=1319376971558146675, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319376331821925278, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792493582858, updateTime=1792493582858, creator=18614031015, updator=18614031015), WebsiteProps(id=1319376971574923894, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319376331821925278, code=themeColor, value=null, createTime=1792493582862, updateTime=1792493582862, creator=18614031015, updator=18614031015), WebsiteProps(id=1319376971583312503, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319376331821925278, code=themeStyle, value=null, createTime=1792493582864, updateTime=1792493582864, creator=18614031015, updator=18614031015)]), Website(id=1319376331905811365, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319373162502258839, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/ljjydxxb/EN, language=EN, createTime=1792493430353, createBy=18614031015, updateTime=1792493548158, updateBy=18614031015, name=陆军军医大学学报-英文, tplId=1146101810881728533, title=Journal of Army Medical University, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1319376935873008230, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319376331905811365, code=articleTextType, value=kx, createTime=1792493574350, updateTime=1792493574350, creator=18614031015, updator=18614031015), WebsiteProps(id=1319376935843648099, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319376331905811365, code=banner, value=null, createTime=1792493574343, updateTime=1792493574343, creator=18614031015, updator=18614031015), WebsiteProps(id=1319376935902368361, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319376331905811365, code=grayFlag, value=0, createTime=1792493574357, updateTime=1792493574357, creator=18614031015, updator=18614031015), WebsiteProps(id=1319376935835259490, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319376331905811365, code=logo, value=https://castjournals.cast.org.cn/joweb/ljjydxxb/EN/file/pic?fileId=Mmvh7crXM7dcUwf9n9+ehg==, createTime=1792493574341, updateTime=1792493574341, creator=18614031015, updator=18614031015), WebsiteProps(id=1319376935914951275, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319376331905811365, code=minRunFlag, value=0, createTime=1792493574360, updateTime=1792493574360, creator=18614031015, updator=18614031015), WebsiteProps(id=1319376935864619621, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319376331905811365, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/ljjydxxb/EN/file/pic, createTime=1792493574348, updateTime=1792493574348, creator=18614031015, updator=18614031015), WebsiteProps(id=1319376935906562666, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319376331905811365, code=silenceFlag, value=0, createTime=1792493574358, updateTime=1792493574358, creator=18614031015, updator=18614031015), WebsiteProps(id=1319376935856231012, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319376331905811365, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792493574346, updateTime=1792493574346, creator=18614031015, updator=18614031015), WebsiteProps(id=1319376935881396839, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319376331905811365, code=themeColor, value=null, createTime=1792493574352, updateTime=1792493574352, creator=18614031015, updator=18614031015), WebsiteProps(id=1319376935889785448, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319376331905811365, code=themeStyle, value=null, createTime=1792493574354, updateTime=1792493574354, creator=18614031015, updator=18614031015)])], journalTitle=陆军军医大学学报, weixinUrl=null, journalUrl=https://aammt.tmmu.edu.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Journal of Army Medical University, journalPhotoCn=zdiTazv9TbsMJqLaCJ/k7A==, journalPhotoEn=931BgeD2k9AIsc7QjHoQKg==, journalFirstLetter=L, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/ljjydxxb/CN/10.16016/j.2097-0927.202505045, detailUrlEn=https://castjournals.cast.org.cn/joweb/ljjydxxb/EN/10.16016/j.2097-0927.202505045, pdfUrlCn=https://castjournals.cast.org.cn/joweb/ljjydxxb/CN/PDF/10.16016/j.2097-0927.202505045, pdfUrlEn=https://castjournals.cast.org.cn/joweb/ljjydxxb/EN/PDF/10.16016/j.2097-0927.202505045, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=1, orderTime=1756483200000, fullTextJson=null, articleText=null, reference=null)